Xavier Llor

This paper develops a systems approach to improve Lynch syndrome diagnosis by enhancing tumor testing and referral processes, resulting in increased genetic testing and LS diagnosis rates.

This study classifies MMR-deficient tumors into subtypes based on mutational signatures and immunogenic potential, revealing clinical and molecular differences.